High Court considers requirements for an exclusive patent licence (Neurim v Mylan)

In the LexisNexis case analysis, Senior IP Associate, Will Smith, talks about the decision in the following matter: Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN) [2020] EWHC 3270 (Pat). This case concerned the licensing of patented technology, specifically the use of licence terms relating to the control of proceedings. 

Click here to read more >

Full article available on PatentHub

Latest insights

More Insights